Telix Pharmaceuticals
Price & Volume
Stats
See more52W Range | $8.93-$30.36 |
Market Cap | $3.2B |
Shares Short | 121,036 |
Financials
See moreRevenue (12 Mos) | $664.2M |
Revenue Growth (YoY) | 58.9% |
Gross Profit (12 Mos) | $358.2M |
Diluted EPS | $0.02 |
News
See moreYahoo Finance • 9 hours ago
Investor Notice: Robbins LLP Informs Investors of the Telix Pharmaceuticals Ltd. Securities Class Action
Yahoo Finance • 13 hours ago
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
About
CEO | Dr. Christian P. Behrenbruch BEng(Hons), DPhil(Oxon), GAICD, J.D., M.B.A., MBA |
Address | 55 Flemington Road, North Melbourne, VIC, Australia, 3051 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
